EBS

Press release - “The Teachers’ Lounge” wins the LUX Audience Award 2024

Retrieved on: 
Thursday, April 18, 2024
Smoke, Democracy, European Parliament, S&D, Fallen Leaves, Adamant, Thought, Imagination, European Film Academy, Heart, EBS, European, EP, Bee, Film industry

“The Teachers’ Lounge” wins the LUX Audience Award 2024

Key Points: 
  • “The Teachers’ Lounge” wins the LUX Audience Award 2024
    “The Teachers’ Lounge” by German director Ilker Çatak won the 2024 LUX European Audience Film Award on Tuesday, in a ceremony in Parliament’s hemicycle in Brussels.
  • The film, produced in Germany, tells a story about Carla, a young high school teacher, distinguished from her colleagues by her idealism.
  • When a series of unsolved thefts sour the atmosphere among the teaching staff, Carla decides to investigate.
  • Press conference and related events
    You can watch the press conference with the winner Evelyn Regner and Mike Downey after the ceremony on EbS and EP Live.

Press release - European Parliament Press Kit for the Special European Council of 17 and 18 April 2024

Retrieved on: 
Thursday, April 18, 2024
Gas, Hamas, Face, ACI, Committee, Special, Seal, S&D, Parliament, Council, Investment, Honey, European Commission, EP, Data Act, Artificial intelligence, Policy, Legislation, Wildfire, Research, War, Delegation, Communication, Speech, Democracy, CFD, Aggression, Poultry, Partnership, Risk, Outline, City, MFF, Brexit, Safety, GAEC, GUE/NGL, SMEI, Pilar del Castillo, Waste, SME, STEP, Weather, Person, Emergency, Electricity, Annual report, Climate change, International trade, Acceleration, Intelligence, Act, Internet, Coercion, AI, Crime, Private sector, Commission, Common Agricultural Policy, Nuclear energy, Security, Single market, Grid, Violence, Mining, Civil service commission, Punishment, EUR, Cyber, Farmer, European Council, Artificial Intelligence Act, EPP, Recycling, European Parliament, COVID-19, Common, CAP, Flood, Hydrogen, EBS, European Defence Fund, Collection, International law, Defense, Government

In this press kit, you will find a selection of the European Parliament’s press releases reflecting MEPs’ priorities for topics on the summit agenda. Source : © European Union, 2024 - EP

Key Points: 


In this press kit, you will find a selection of the European Parliament’s press releases reflecting MEPs’ priorities for topics on the summit agenda. Source : © European Union, 2024 - EP

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

Retrieved on: 
Thursday, March 28, 2024
FSA, U.S. FDA, Arm, Heroin, Risk, Education, Pharmacy, School, Naloxone, Policy, EBS, Flexible, House, Drug, OTC, CDC, Restaurant, Medicaid, National Safety Council, AED, HSA, FDA, Emergent BioSolutions, NSC, Medicine, Fentanyl, Pharmaceutical industry

Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.

Key Points: 
  • Emergent and other stakeholders in the fight must continue raising awareness about the availability of products like NARCAN® Nasal Spray, reducing stigma and further improving access for all Americans.
  • Since the OTC launch, NARCAN® Nasal Spray can be purchased at more than 32,000 mass drug, grocery, online retailers and e-commerce sites.
  • Emergent is working with retail partners to make it easy to find and access, however each retailer ultimately determines in-store product placement.
  • “That’s why we remain committed to increasing awareness of NARCAN® Nasal Spray availability.

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

Retrieved on: 
Monday, March 25, 2024
Letter, Emergent, Risk, Patient, CGMP, Ethics, Classification, News, EBS, Life, NAI, Emergent BioSolutions, VAI, FDA, Food, Management

GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has listed “No Action Indicated” or NAI status classification for the company's Baltimore Bayview manufacturing facility.

Key Points: 
  • GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has listed “No Action Indicated” or NAI status classification for the company's Baltimore Bayview manufacturing facility.
  • Based on this outcome, the Baltimore Bayview facility is considered to be in an acceptable state of compliance with regard to current good manufacturing practices (cGMP).
  • “We will continue to put quality and compliance first in our manufacturing operations to ensure we’re delivering high quality products to our customers and patients.”
    The result of obtaining NAI status in Bayview is a continuation of Emergent’s strong commitment to quality and compliance.
  • In 2023, Emergent manufacturing facilities were successfully inspected by five regulatory agencies across the globe and five other inspectional bodies for 18 inspections, including three by the FDA that resulted in NAI or VAI status.

Kubecost Launches Kubecost 2.2 with Carbon Cost Monitoring, Broader Cloud Cost Visibility, Disk Autoscaling, and More

Retrieved on: 
Tuesday, March 19, 2024
Carbon, Cloud, Automation, Organization, Forecasting, Environment, SAN, EBS, DevOps, InfoWorld, Engineering, Renewable energy

The release significantly extends the platform’s capabilities for cloud cost monitoring and optimization at scale.

Key Points: 
  • The release significantly extends the platform’s capabilities for cloud cost monitoring and optimization at scale.
  • Customers can use Carbon Cost Monitoring to conduct energy audits and easily compare financial and environmental costs across any business cost center (department, application, etc.).
  • Datadog Cost Monitoring: Kubecost now provides unified cloud cost monitoring for organizations seeking to observe and optimize Kubernetes, cloud, and Datadog costs in one place.
  • Disk Autoscaler: Built for DevOps teams and Kubernetes administrators, Kubecost automates disk scaling based on EBS persistent volume utilization.

CME Group €STR Options to Launch on May 20

Retrieved on: 
Tuesday, April 2, 2024
LTD, COMEX, CME Group, Risk, New York Mercantile Exchange, Financial services, City, CBOT, Metal, EBS, Chicago Board of Trade, NYMEX, S&P, CME, S&P Dow Jones Indices, OTC, Standard

CHICAGO, April 2, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch options on Euro short-term rate (€STR) futures on May 20, 2024.

Key Points: 
  • CHICAGO, April 2, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch options on Euro short-term rate (€STR) futures on May 20, 2024.
  • "Our new €STR options will help clients more precisely manage their risk as expectations around European interest rate decisions continue to shift," said Mark Rogerson, EMEA Head of Interest Rate Products, CME Group.
  • CME Group launched the industry's first €STR futures on October 31, 2022 as a complement to SOFR futures.
  • €STR options will be listed by and subject to the rules of CME Group.

CME Group Reports March and Q1 2024 Market Statistics

Retrieved on: 
Tuesday, April 2, 2024
LTD, COMEX, CME Group, New York Mercantile Exchange, Financial services, City, CBOT, Metal, EBS, Chicago Board of Trade, NYMEX, S&P, CME, S&P Dow Jones Indices, OTC, ADV, Standard, Iron ore

CHICAGO, April 2, 2024 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today reported its March and Q1 2024 market statistics, showing average daily volume (ADV) reached 24.3 million contracts in March and 26.4 million contracts in Q1.

Key Points: 
  • CHICAGO, April 2, 2024 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today reported its March and Q1 2024 market statistics, showing average daily volume (ADV) reached 24.3 million contracts in March and 26.4 million contracts in Q1.
  • Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume .
  • March 2024 ADV across asset classes includes:
    Additional March 2024 product highlights compared to March 2023 include:
    Q1 2024 highlights across asset classes compared to Q1 2023 include:
    As the world's leading derivatives marketplace, CME Group ( www.cmegroup.com ) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities.
  • CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates , equity indexes , foreign exchange , energy , agricultural products and metals .

CME Group Inc. Announces First-Quarter 2024 Earnings Release, Conference Call

Retrieved on: 
Friday, March 15, 2024
LTD, COMEX, CME Group, Telephone, New York Mercantile Exchange, Financial services, City, CBOT, Metal, EBS, Chicago Board of Trade, NYMEX, S&P, CME, S&P Dow Jones Indices, OTC, Standard, Central Time

CHICAGO, March 15, 2024 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2024 before the markets open on Wednesday, April 24, 2024.

Key Points: 
  • CHICAGO, March 15, 2024 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2024 before the markets open on Wednesday, April 24, 2024.
  • Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release.
  • The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.
  • A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website, www.cmegroup.com .

Press release - European Parliament Press Kit for the European Council of 21 and 22 March 2024

Retrieved on: 
Wednesday, April 3, 2024
Friends, Hamas, Letter, Committee, Foreign Affairs Committee, S&D, Parliament, Policy, War, Communication, Speech, Democracy, Commissioner, Aggression, Risk, City, Foreign, Kremlin, Enlargement, Reform, Person, Development, Annual report, Republic, Acceleration, Foreign Affairs, Crime, Death, Commission, Security, Balkans, Violence, Punishment, Farmer, Growth, European Council, EPP, European Parliament, Alexei Navalny, Committee on Agriculture, Security policy, EBS, International law, Government, UN

In this press kit, you will find a selection of the European Parliament’s press releases reflecting MEPs’ priorities for topics on the summit agenda. Source : © European Union, 2024 - EP

Key Points: 


In this press kit, you will find a selection of the European Parliament’s press releases reflecting MEPs’ priorities for topics on the summit agenda. Source : © European Union, 2024 - EP

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

Retrieved on: 
Thursday, February 29, 2024
EBS, ID, Webcast, Telephone, Emergent BioSolutions

GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, March 6, 2024, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2023.

Key Points: 
  • GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, March 6, 2024, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2023.
  • Emergent’s newly appointed president and CEO, Joseph C. Papa, will provide remarks.
  • Participants can access the conference call live via webcast from the Investors page of Emergent’s website.
  • A replay of the call can be accessed from the Investors page of Emergent’s website.